Mean Systemic Filling Pressure and Heart Performance Predicting Fluid Responsiveness in Sepsis

January 23, 2018 updated by: L.P.B. Meijs, Catharina Ziekenhuis Eindhoven

Mean Systemic Filling Pressure and Heart Performance as Predictors of Successful Fluid Responsiveness in Patients With Sepsis

The purpose of this study is to determine fluid responsiveness in critically ill patients by measuring mean systemic filling pressure on the intensive care unit.

Study Overview

Status

Unknown

Detailed Description

The assessment of the cardiovascular state in critically ill patients is subject to difficulties in terms of the fact that several hemodynamic parameters, for example mean arterial blood pressure (MAP) and cardiac output (CO) supply insufficient information about the circulating volume and cardiac performance. There is a clinical need to adequate determination of intravascular volume status and therefore reliable predictors of fluid responsiveness are highly relevant. However, in determining the fluid status of a patient, the lack of appreciation of the venous side of the circulation persists today, which is greatly due to the inability to appropriately assess the venous side of the circulation. The importance of the venous part of the circulation is moreover reflected by the fact that an increase in venous resistance does reduce CO many times more than a similar increase in arterial resistance. Mean systemic filling pressure (Pms), which is defined as the pressure equal to the pressure which would be measured if the heart should suddenly stop pumping and all (arterial and venous) the pressures in the entire circulatory system should be brought to equilibrium instantaneously, is a good, complete and reliable reflection of the total intravascular fluid compartment. Passive leg raising (PLR) represents a "self-volume challenge" that predicts preload responsiveness and the transient hemodynamic changes on venous return can be directly monitored in ventilated patients, provided that there is an intact circulation, in order to test the amount of volume responsiveness.

Study Type

Observational

Enrollment (Anticipated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • North Brabant
      • Eindhoven, North Brabant, Netherlands, 5623 EJ
        • Recruiting
        • Catharina Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • Loek Meijs, MD
        • Principal Investigator:
          • A.J.G.H. Bindels, PhD
        • Sub-Investigator:
          • A. Roos, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 120 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Septic patients on ICU

Description

Inclusion Criteria:

  • Patients must be older than 18 years, and must be equipped with a pulse-contour cardiac output system with a central venous catheter.
  • Patients will be subsequently connected to the hemodynamic monitoring device Navigator™.
  • In those patients with clinical signs of inadequate tissue perfusion, passive leg raising and standardized fluid challenge will be performed.

Exclusion Criteria:

  • Patients with assist devices (e.g. intra aortic balloon pump, Impella®, ECMO), patients with arrhythmias (either atrial of ventricular) will be excluded from the study.
  • Also, patients with inguinal impairment or contraindications for a passive leg raising will be excluded (such as deep venous thrombosis or elastic compression stocking), head trauma, an increase intra-abdominal pressure suspected by clinical context and examination as well as patients with absolute contraindications for fluid challenge.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Sepsis
Patients diagnosed with septic shock, admitted to the intensive care unit, with a good left ventricular ejection fraction without significant co-morbidity are highly eligible for this study. Patients must be equipped with a pulse-contour cardiac output (PICCO)-system with a central venous catheter which will be applied by the intensivist on admission.Patients will be subsequently connected to the hemodynamic monitoring device Navigator™. In those patients with clinical signs of inadequate tissue perfusion, passive leg raising and standardized fluid challenge will be performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean systemic filling pressure (Pms)
Time Frame: 1 hour
An increase in mean systemic filling pressure after (self)volume-challenge indicating volume responsiveness of the patient
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart performance (eH)
Time Frame: 1 hour
Quotient of driving pressure of venous return in mmHg
1 hour

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Secondary hemodynamic parameters
Time Frame: 1 hour
Heart Rate
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
Mean Arterial Blood Pressure
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
Cardiac Index
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
Central Venous Pressure
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
Systemic Vascular Resistance
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
Pulse Pressure Variation
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
Pulmonary Vascular Permeability Index
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
Plethysmographic Oxygen Saturation
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
Delivery of Oxygen Index
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
Mechanical Ventilation Settings
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
End-tidal CO2
1 hour
Secondary hemodynamic parameters
Time Frame: 1 hour
Peripheral Temperature
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (Anticipated)

May 1, 2019

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

May 18, 2016

First Submitted That Met QC Criteria

May 19, 2016

First Posted (Estimate)

May 20, 2016

Study Record Updates

Last Update Posted (Actual)

January 25, 2018

Last Update Submitted That Met QC Criteria

January 23, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • M12-1272

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

No, data remain anonymized within hospital and property of PI.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Output, High

3
Subscribe